Physician profile
Kelly A Wright
NPI 1972021319
$2,210.90
in general payments reported to CMS, 2019-2025
24 companies · $37.69 in 2025
The $37.69 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,085 · 2022: $1,000 · 2023: $88.28 · 2025: $37.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $530.82 | 2021-2023 | Rybelsus, Ozempic |
| Abbvie INC. | $314.13 | 2021-2023 | |
| Lilly USA, LLC | $239.78 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $175.67 | 2021-2022 | |
| Amgen INC. | $136.70 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $121.83 | 2021-2022 | |
| Horizon Therapeutics Plc | $90.15 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $82.68 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $52.24 | 2021 | |
| Redhill Biopharma INC. | $51.64 | 2021 | |
| Glaxosmithkline, LLC. | $46.01 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $42.59 | 2022 | |
| Pfizer INC. | $42.09 | 2021 | |
| Abbott Laboratories | $39.74 | 2023 | Freestyle Libre 2 |
| Esperion Therapeutics, INC. | $38.91 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $37.69 | 2025 | Axonics |
| Shield Therapeutics INC | $37.06 | 2022 | |
| Janssen Pharmaceuticals, INC | $32.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.87 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.07 | 2021 | |
| Merck Sharp & Dohme LLC | $15.67 | 2021 | |
| Currax Pharmaceuticals LLC | $14.54 | 2021 | |
| Astellas Pharma US INC | $13.40 | 2021 | |
| Qol Medical, LLC | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.